Thalidomide Celgene е определено като „ лекарство сирак ” (лекарство, използвано при редки заболявания).
Because the number of patients with multiple myeloma is low, the disease is considered ‘ rare’, and Thalidomide Celgene was designated an ‘ orphan medicine ’ (a medicine used in rare diseases) on 20 November 2001.